>
Switch to:

Altamira Therapeutics PB Ratio

: 1.02 (As of Today)
View and export this data going back to 2014. Start your Free Trial

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2021-10-28), Altamira Therapeutics's share price is $1.6907. Altamira Therapeutics's Book Value per Share for the fiscal year that ended in Dec. 2020 was $1.65. Hence, Altamira Therapeutics's PB Ratio of today is 1.02.

The historical rank and industry rank for Altamira Therapeutics's PB Ratio or its related term are showing as below:

NAS:CYTO' s PB Ratio Range Over the Past 10 Years
Min: 1.01   Med: 1.87   Max: 2.66
Current: 1.02

1.01
2.66

During the past 10 years, Altamira Therapeutics's highest PB Ratio was 2.66. The lowest was 1.01. And the median was 1.87.

NAS:CYTO's PB Ratio is ranked lower than
96% of the 270 Companies
in the Biotechnology industry.

( Industry Median: 4.30 vs. NAS:CYTO: 1.02 )

During the past 12 months, Altamira Therapeutics's average Book Value Per Share Growth Rate was 74.20% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Altamira Therapeutics was -45.00% per year. The lowest was -80.10% per year. And the median was -73.60% per year.

Back to Basics: PB Ratio


Altamira Therapeutics PB Ratio Historical Data

The historical data trend for Altamira Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altamira Therapeutics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
PB Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.65 - 4.40 1.09 1.58

Altamira Therapeutics Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
PB Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 1.09 1.00 1.58 2.20

Competitive Comparison

For the Biotechnology subindustry, Altamira Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Altamira Therapeutics PB Ratio Distribution

For the Biotechnology industry and Healthcare sector, Altamira Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Altamira Therapeutics's PB Ratio falls into.



Altamira Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Altamira Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (A: Dec. 2020)
=1.6907/1.653
=1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Altamira Therapeutics  (NAS:CYTO) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Altamira Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Altamira Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Altamira Therapeutics Business Description

Altamira Therapeutics logo
Industry
Healthcare » Biotechnology NAICS : 541714 SIC : 2834
Traded in Other Exchanges
Address
8 The Green, Suite 12455, Dover, DE, USA, 19901
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

Altamira Therapeutics Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)